Receptores A3 da adenosina: uma nova abordagem terapêutica no câncer
Cancer is a multi-factorial disease linked with different initiating causes, cofactors and promoters, and several types of cellular damage. Advancing knowledge on the cellular and molecular biology of the processes that regulate cell proliferation, cell differentiation and cellular responses to exte...
Main Authors: | Alexandra Gaspar, Tiago Silva, Fernanda Borges |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Química
2011-01-01
|
Series: | Química Nova |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422011000800022&lng=en&tlng=en |
Similar Items
-
Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
by: Ramesh Narayanan
Published: (2020-07-01) -
Psicofarmacogenética: uma nova abordagem terapêutica
by: Homero Pinto Vallada Filho
Published: (1999-10-01) -
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
by: Gaetano Aurilio, et al.
Published: (2020-12-01) -
Nutlin3a Contributes to the Cytoplasmic Retention of Androgen Receptor
by: Gulseren Ozduman, et al.
Published: (2018-12-01) -
Comparative Study of Carborane- and Phenyl-Modified Adenosine Derivatives as Ligands for the A2A and A3 Adenosine Receptors Based on a Rigid in Silico Docking and Radioligand Replacement Assay
by: Marian Vincenzi, et al.
Published: (2018-07-01)